Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Technology and Code

Published on 29 Jan 2025

VIBE: an R-package for VIsualization of Bulk RNA Expression data for therapeutic targeting and disease stratification

in Cancer Molecular Targets and Therapeutics

Indu Khatri
Saskia D. van Asten
Leandro F. Moreno
Brandon W. Higgs
Christiaan Klijn
Francis Blokzijl
Iris C. R. M. Kolder

Frontiers in Oncology

doi 10.3389/fonc.2024.1441133

1,100 views

Original Research

Published on 29 Jan 2025

Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway

in Cancer Molecular Targets and Therapeutics

Xing Luo
Yi Duan
Jinwei He
CongGai Huang
Jun Liu
Yifan Liu
Mengdei Xu
Qiong Dai
Zhihui Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1429018

693 views

Review

Published on 23 Jan 2025

Ferroptosis in thyroid cancer: mechanisms, current status, and treatment

in Cancer Molecular Targets and Therapeutics

Wenzhi Tian
Xi Su
Chenchen Hu
Dong Chen
Peng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1495617

1,473 views

Review

Published on 22 Jan 2025

Natural killer cell engagers for cancer immunotherapy

in Cancer Molecular Targets and Therapeutics

Shahryar Khoshtinat Nikkhoi
Geng Li
Arash Hatefi

Frontiers in Oncology

doi 10.3389/fonc.2024.1483884

2,683 views

Original Research

Published on 22 Jan 2025

Apoptosis antagonizing transcription factor expression and its validation as a potential diagnostic and prognostic biomarker in oral squamous cell carcinoma

in Cancer Molecular Targets and Therapeutics

Ainiwaerjiang Abudourousuli
Zumulaiti Aierken
Hasiyati Mamuti
Tuxunayi Yimamu
Chengli Da

Frontiers in Oncology

doi 10.3389/fonc.2025.1542730

801 views

Original Research

Published on 16 Jan 2025

Implication of fibroblast growth factor 7 in ovarian cancer metastases and patient survival

in Cancer Molecular Targets and Therapeutics

Laura F. Mortan
Brooke A. Meelheim
Justin Garland
Jacqueline A. Bohn
Zitha Redempta Isingizwe
Doris M. Benbrook

Frontiers in Oncology

doi 10.3389/fonc.2024.1524606

955 views

Original Research

Published on 16 Jan 2025

Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67

in Cancer Molecular Targets and Therapeutics

Rende Peng
Yaoyu Zhang
Mingzhu Jia
Xinping Yi
Xiaoyao Yi
Shadan Li
Jiangchuan Pi
Wenjun Meng

Frontiers in Oncology

doi 10.3389/fonc.2024.1522009

1,319 views

Case Report

Published on 15 Jan 2025

Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case

in Cancer Molecular Targets and Therapeutics

Raffaella Pagliaro
Paola Maria Medusa
Fabiana Vitiello
Luigi Aronne
Susan F. M. Campbell
Fabio Perrotta
Andrea Bianco

Frontiers in Oncology

doi 10.3389/fonc.2024.1500449

1,237 views

Systematic Review

Published on 15 Jan 2025

First-line treatment for advanced or metastatic EGFR mutation-positive non-squamous non-small cell lung cancer: a network meta-analysis

in Cancer Molecular Targets and Therapeutics

Mengyao Zhang
Lan Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1498518

1,798 views

Original Research

Published on 14 Jan 2025

Efficacy and safety of anlotinib as maintenance treatment in extensive-stage small cell lung cancer: a single-armed single center retrospective study

in Cancer Molecular Targets and Therapeutics

Jin Xiong
Lei Xia

Frontiers in Oncology

doi 10.3389/fonc.2024.1462581

748 views

Original Research

Published on 09 Jan 2025

Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells infected with oncolytic herpes simplex virus-1

in Cancer Molecular Targets and Therapeutics

Naeme Javid
Shahriyar Abdoli
Majid Shahbazi

Frontiers in Oncology

doi 10.3389/fonc.2024.1469511

1,240 views

Review

Published on 09 Jan 2025

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates

in Cancer Molecular Targets and Therapeutics

Yangyang Gao
Yuwei Xia
Yixin Chen
Shiqi Zhou
Yingying Fang
Jieru Yu
Leyin Zhang
Leitao Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1459368

2,266 views

Original Research

Published on 09 Jan 2025

Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways

in Cancer Molecular Targets and Therapeutics

Yu Zhang
Hailong Lun
Naiqiang Zhu
Ning Yang
Kaikai Ding
Bin Chen
Chengbing Chang
Haipeng Gu
Yanqi Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1485605

1,283 views

Original Research

Published on 07 Jan 2025

Machine learning-based identification of proteomic markers in colorectal cancer using UK Biobank data

in Cancer Molecular Targets and Therapeutics

Swarnima Kollampallath Radhakrishnan
Dipanwita Nath
Dominic Russ
Laura Bravo Merodio
Priyani Lad
Folakemi Kola Daisi
Animesh Acharjee

Frontiers in Oncology

doi 10.3389/fonc.2024.1505675

2,712 views
2 citations

Systematic review

Published on 07 Jan 2025

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Bowen Dai
Jiaping Jiang
Xiaoyu Yu
Haihua Zhan
Zhengchuan Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1515992

774 views

Review

Published on 07 Jan 2025

Advances and current concepts on Eph receptors and ephrins in upper digestive tract cancers

in Cancer Molecular Targets and Therapeutics

Luccas Lavareze
Talita de Carvalho Kimura
João Figueira Scarini
Reydson Alcides de Lima-Souza
Moisés Willian Aparecido Gonçalves
Raisa Sales de Sá
Iara Gonçalves Aquino
Patricia Maria Fernandes
Fernanda Cristina Poscai Ribeiro
Albina Altemani

Frontiers in Oncology

doi 10.3389/fonc.2024.1520306

790 views